Efficacy and Safety of Amantadine Hydrogen Chloride (HCl) ER Tablets in Parkinson's Disease Subjects With LID
Public ClinicalTrials.gov record NCT02153632. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Placebo-controlled, Double-blind, 26 Week Study to Evaluate the Efficacy and Safety of Amantadine HCl Extended Release Tablets in Parkinson's Disease Subjects With Levodopa-Induced Dyskinesias
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this multi-center, randomized, double-blind, parallel-group, 26 week study is to compare the efficacy and safety of two different dose levels of Amantadine Extended Release Tablets to placebo for the treatment of levodopa induced dyskinesia in patients with Parkinson's disease.
Study identification
- NCT ID
- NCT02153632
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 135 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 30 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 30, 2014 (Actual)
- Primary completion
- May 20, 2016 (Actual)
- Completion
- May 20, 2016 (Actual)
- Last update posted
- Feb 16, 2022
2014 – 2016
United States locations
- U.S. sites
- 24
- U.S. states
- 16
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Tucson | Arizona | 85724 | — |
| Not listed | Fountain Valley | California | 92708 | — |
| Not listed | Irvine | California | 92602 | — |
| Not listed | Pasadena | California | 91105 | — |
| Not listed | Ventura | California | 93001 | — |
| Not listed | Boulder | Colorado | 80304 | — |
| Not listed | Hollywood | Florida | 33021 | — |
| Not listed | Miami | Florida | 40502 | — |
| Not listed | North Palm Beach | Florida | 33404 | — |
| Not listed | Sarasota | Florida | 34243 | — |
| Not listed | Tampa | Florida | 33612 | — |
| Not listed | Chicago | Illinois | 60612 | — |
| Not listed | Indianapolis | Indiana | 46202 | — |
| Not listed | Lexington | Kentucky | 40502 | — |
| Not listed | Baton Rouge | Louisiana | 70810 | — |
| Not listed | Ann Arbor | Michigan | 48103 | — |
| Not listed | Summit | New Jersey | 07901 | — |
| Not listed | Brooklyn | New York | 11215 | — |
| Not listed | Patchogue | New York | 11772 | — |
| Not listed | Raleigh | North Carolina | 27612 | — |
| Not listed | Columbus | Ohio | 43004 | — |
| Not listed | Round Rock | Texas | 78681 | — |
| Not listed | Orem | Utah | 84058 | — |
| Not listed | Kirkland | Washington | 98033 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 32 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02153632, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 16, 2022 · Synced Oct 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02153632 live on ClinicalTrials.gov.